Epigenetics of the depressed brain: Role of histone acetylation and methylation

Neuropsychopharmacology

Volumn 38, Issue 1, 2013, Pages 124-137

  Sun, Haosheng ^a   Kennedy, Pamela J ^a   Nestler, Eric J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acetylation; chromatin; depression; epigenetics; methylation; psychiatry

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; ENTINOSTAT; FLUOXETINE; HISTONE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HISTONE METHYLTRANSFERASE; IMIPRAMINE; LYSINE; MESSENGER RNA; SIRTUIN; SPACER DNA;

ACUTE STRESS; AMYGDALOID NUCLEUS; ANHEDONIA; ANTIDEPRESSANT ACTIVITY; BRAIN REGION; CHROMATIN; CHROMATIN STRUCTURE; CHRONIC STRESS; DENTATE GYRUS; DEPRESSION; DRUG MECHANISM; EPIGENETICS; FORCED SWIMMING TEST; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HIPPOCAMPUS; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TRANSCRIPTION INITIATION;

ACETYLATION; ANIMALS; BRAIN; BRAIN CHEMISTRY; DEPRESSIVE DISORDER, MAJOR; EPIGENESIS, GENETIC; HISTONES; HUMANS; METHYLATION; NERVE NET;

EID: 84869096094     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.73     Document Type: Review

References (139)

1. Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F et al (2011). Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res 45: 1106-1112.
2. Allan J, Mitchell T, Harborne N, Bohm L, Crane-Robinson C (1986). Roles of H1 domains in determining higher order chromatin structure and H1 location. J Mol Biol 187: 591-601.
3. Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N et al (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387: 49-55.
4. Allfrey VG, Faulkner R, Mirsky AE (1964). Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51: 786-794.
5. American Psychiatric Association (2000). Diagnostic Criteria from DSM-IV-TR. American Psychiatric Association: Washington, D.C.
6. Balu DT, Hodes GE, Anderson BT, Lucki I (2009). Enhanced sensitivity of the MRL/ MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology 34: 1764-1773.
7. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW et al (2003). Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121: 847-853.
8. Benraiss A, Chmielnicki E, Lerner K, Roh D, Goldman SA (2001). Adenoviral brainderived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci 21: 6718-6731.
9. Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD et al (2011). Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl) 221: 297-315.
10. Berger SL (2007). The complex language of chromatin regulation during transcription. Nature 447: 407-412.
11. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ et al (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311: 864-868.
12. Bilang-Bleuel A, Ulbricht S, Chandramohan Y, De Carli S, Droste SK, Reul JM (2005). Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptordependent behavioural response. Eur J Neurosci 22: 1691-1700.
13. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P (2008). Decoding the epigenetic language of neuronal plasticity. Neuron 60: 961-974.
14. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D et al (2011). Poor replication of candidate genes for major depressive disorder using genomewide association data. Mol Psychiatry 16: 516-532.
15. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY et al (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84: 843-851.
16. Caberlotto L, Hurd YL (2001). Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 25: 91-97.
17. Cary PD, Crane-Robinson C, Bradbury EM, Dixon GH (1982). Effect of acetylation on the binding of N-terminal peptides of histone H4 to DNA. Eur J Biochem 127: 137-143.
18. Chandramohan Y, Droste SK, Arthur JS, Reul JM (2008). The forced swimminginduced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen-and stress-activated kinase signalling pathway. Eur J Neurosci 27: 2701-2713.
19. Charney DS, Manji HK (2004) Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004: re5.
20. Choi JK, Howe LJ (2009) Histone acetylation: truth of consequences? Biochem Cell Biol 87: 139-150.
21. Christoffel DJ, Golden SA, Dumitriu D, Robison AJ, Janssen WG, Ahn HF et al (2011). IkappaB kinase regulates social defeat stress-induced synaptic and behavioral plasticity. J Neurosci 31: 314-321.
22. Cook SC, Wellman CL (2004). Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60: 236-248.
23. Coppell AL, Pei Q, Zetterstrom TS (2003). Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44: 903-910.
24. Covington 3rd HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O et al (2009). Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29: 11451-11460.
25. Covington 3rd HE, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY et al (2011a). A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71: 656-670.
26. Covington 3rd HE, Vialou VF, LaPlant Q, Ohnishi YN, Nestler EJ (2011b). Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci Lett 493: 122-126.
27. Cryan JF, Page ME, Lucki I (2002). Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436: 197-205.
28. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
29. Drevets WC (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11: 240-249.
30. Drevets WC (2003). Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 985: 420-444.
31. Drevets WC (2007). Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 1121: 499-527.
32. Drevets WC, Savitz J, Trimble M (2008). The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13: 663-681.
33. Dudley KJ, Li X, Kobor MS, Kippin TE, Bredy TW (2011). Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci Biobehav Rev 35: 1544-1551.
34. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60: 804-815.
35. Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J et al (2006). Lack of ventral striatal response to positive stimuli in depressed vs normal subjects. Am J Psychiatry 163: 1784-1790.
36. Ernst C, Chen ES, Turecki G (2009). Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol Psychiatry 14: 830-832.
37. Fan GP (2012). DNA methylation: basic mechanisms. Neuropsychopharmacol Reviews (this issue).
38. Ferland CL, Schrader LA (2011). Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. Neuroscience 174: 104-114.
39. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML et al (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609.
40. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J et al (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61: 877-889.
41. Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S (2009). Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 12: 73-82.
42. Fumagalli F, Bedogni F, Perez J, Racagni G, Riva MA (2004). Corticostriatal brainderived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 20: 1348-1354.
43. Gambrill AC, Barria A (2011). NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci USA 108: 5855-5860.
44. Gao L, Cueto MA, Asselbergs F, Atadja P (2002). Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277: 25748-25755.
45. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G et al (2005). Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234-238.
46. Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF (2010). Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci 30: 16970-16982.
47. Gold PW, Chrousos GP (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7: 254-275.
48. Goldwater DS, Pavlides C, Hunter RG, Bloss EB, Hof PR, McEwen BS et al (2009). Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. Neuroscience 164: 798-808.
49. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T et al (2008). Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13: 717-728.
50. Grant PA, Berger SL (1999). Histone acetyltransferase complexes. Semin Cell Dev Biol 10: 169-177.
51. Gundersen BB, Blendy JA (2009). Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 57: 67-74.
52. Hammen C (2005). Stress and depression. Annu Rev Clin Psychol 1: 293-319.
53. Harrison PJ (2002). The neuropathology of primary mood disorder. Brain 125: 1428-1449.
54. Harwood AJ (2003). Neurodevelopment and mood stabilizers. Curr Mol Med 3: 472-482.
55. Heilig M (2004). The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224.
56. Heine VM, Zareno J, Maslam S, Joels M, Lucassen PJ (2005). Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci 21: 1304-1314.
57. Hildmann C, Riester D, Schwienhorst A (2007). Histone deacetylasesFan important class of cellular regulators with a variety of functions. Appl Microbiol Biotechnol 75: 487-497.
58. Hobara T, Uchida S, Otsuki K, Matsubara T, Funato H, Matsuo K et al (2010). Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res 44: 263-270.
59. Hollis F, Duclot F, Gunjan A, Kabbaj M (2011). Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus. Horm Behav 59: 331-337.
60. Hunter RG, McCarthy KJ, Milne TA, Pfaff DW, McEwen BS (2009). Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc Natl Acad Sci USA 106: 20912-20917.
61. Iga J, Ueno S, Yamauchi K, Numata S, Kinouchi S, Tayoshi-Shibuya S et al (2007). Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 31: 628-632.
62. Izzo A, Schneider R (2010). Chatting histone modifications in mammals. Brief Funct Genomics 9: 429-443.
63. Jablonka E, Lamb MJ (2002). The changing concept of epigenetics. Ann N Y Acad Sci 981: 82-96.
64. Jiang Y, Jakovcevski M, Bharadwaj R, Connor C, Schroeder FA, Lin CL et al (2010). Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J Neurosci 30: 7152-7167.
65. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN et al (2005). Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135: 1295-1307.
66. Karolewicz B, Szebeni K, Gilmore T, Maciag D, Stockmeier CA, Ordway GA (2009). Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol 12: 143-153.
67. Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castren E (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol 19: 97-108.
68. Kendler KS (1983). Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry 140: 1413-1425.
69. Kendler KS (1998). Anna-Monika-Prize paper. Major depression and the environment: a psychiatric genetic perspective. Pharmacopsychiatry 31: 5-9.
70. Kessler RC (1997). The effects of stressful life events on depression. Annu Rev Psychol 48: 191-214.
71. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
72. Khan SN, Khan AU (2010). Role of histone acetylation in cell physiology and diseases: an update. Clin Chim Acta 411: 1401-1411.
73. Koo JW, Duman RS (2008). IL-1beta is an essential mediaor of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105: 751-756.
74. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010). Nuclear factorkappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 107: 2669-2674.
75. Kouzarides T (2007). Chromatin modifications and their function. Cell 128: 693-705.
76. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ et al (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131: 391-404.
77. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature 455: 894-902.
78. Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R (2006). Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13: 563-567.
79. Lesch KP (2011). When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience. Curr Top Behav Neurosci 7: 251-280.
80. Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR et al (2006). Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 26: 7870-7874.
81. Lutter LC, Judis L, Paretti RF (1992). Effects of histone acetylation on chromatin topology in vivo. Mol Cell Biol 12: 5004-5014.
82. Maze I, Covington 3rd HE, Dietz DM, LaPlant Q, Renthal W, Russo SJ et al (2010). Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327: 213-216.
83. Maze I, Feng J, Wilkinson MB, Sun H, Shen L, Nestler EJ (2011). Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens. Proc Natl Acad Sci USA 108: 3035-3040.
84. Maze I, Noh K, Allis CD (2012). Histone regulation in the CNS: basic principles of epigenetic plasticity. Neurospychopharmacol Reviews (this issue).
85. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M et al (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12: 342-348.
86. McGowan PO, Suderman M, Sasaki A, Huang TC, Hallett M, Meaney MJ et al (2011). Broad epigenetic signature of maternal care in the brain of adult rats. PLoS One 6: e14739.
87. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S et al (2007). Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61: 187-197.
88. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fischer D et al (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12: 1559-1566.
89. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442.
90. Mutskov V, Gerber D, Angelov D, Ausio J, Workman J, Dimitrov S (1998). Persistent interactions of core histone tails with nucleosomal DNA following acetylation and transcription factor binding. Mol Cell Biol 18: 6293-6304.
91. Nestler EJ, Carlezon Jr WA (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
92. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK et al (2002). Preclinical models: status of basic research in depression. Biol Psychiatry 52: 503-528.
93. Nestler EJ, Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161-1169.
94. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
95. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
96. Onishchenko N, Karpova N, Sabri F, Castren E, Ceccatelli S (2008). Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem 106: 1378-1387.
97. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB (2001). Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 21: 6706-6717.
98. Peter CJ, Akbarian S (2011). Balancing histone methylation activities in psychiatric disorders. Trends Mol Med 17: 372-379.
99. Radley JJ, Kabbaj M, Jacobson L, Heydendael W, Yehuda R, Herman JP (2011). Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes. Stress 14: 481-497.
100. Renthal W, Maze I, Krishnan V, Covington 3rd HE, Xiao G, Kumar A et al (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56: 517-529.
101. Renthal W, Nestler EJ (2009). Chromatin regulation in drug addiction and depression. Dialogues Clin Neurosci 11: 257-268.
102. Reul JM, Chandramohan Y (2007). Epigenetic mechanisms in stress-related memory formation. Psychoneuroendocrinology 32(Suppl 1): S21-S25.
103. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V et al (2009). Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 29: 3529-3537.
104. Russo VEA, Martienssen RA, Riggs AD (1996). Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor Laboratory Press: Plainview, N.Y.
105. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007). Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62: 55-64.
106. Schwer B, Verdin E (2008). Conserved metabolic regulatory functions of sirtuins. Cell Metab 7: 104-112.
107. Selvi RB, Kundu TK (2009). Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Biotechnol J 4: 375-390.
108. Semba J, Kuroda Y, Takahashi R (1989). Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice. Neuropsychobiology 21: 152-156.
109. Sheline YI (2003). Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54: 338-352.
110. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75.
111. Sterrenburg L, Gaszner B, Boerrigter J, Santbergen L, Bramini M, Elliott E et al (2011). Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. PLoS One 6: e28128.
112. Strahl BD, Allis CD (2000). The language of covalent histone modifications. Nature 403: 41-45.
113. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157: 1552-1562.
114. Taunton J, Hassig CA, Schreiber SL (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408-411.
115. Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ et al (2007). The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 27: 12156-12167.
116. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9: 519-525.
117. Tsankova NM, Kumar A, Nestler EJ (2004). Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24: 5603-5610.
118. Tse C, Sera T, Wolffe AP, Hansen JC (1998). Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol 18: 4629-4638.
119. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T et al (2011). Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69: 359-372.
120. Vialou V, Feng J, Robison AJ, Nestler EJ (2012). Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Exp Ther (e-pup ahead of print).
121. Waddington CH (1940). Organisers & Genes. The University Press: Cambridge Eng.
122. Waddington CH (1957). The Strategy of the Genes; a Discussion of Some Aspects of Theoretical Biology. Allen & Unwin: London.
123. Waddington CH (1968). Towards a Theoretical Biology; An IUBS Symposium. Edinburgh U.P: Edinburgh.
124. Wallace DL, Han MH, Graham DL, Green TA, Vialou V, Iniguez SD et al (2009). CREB regulation of nucleus accumbens excitability mediates social isolationinduced behavioral deficits. Nat Neurosci 12: 200-209.
125. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S et al (2008). Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.
126. Warner-Schmidt JL, Duman RS (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA 104: 4647-4652.
127. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al (2004). Epigenetic programming by maternal behavior. Nat Neurosci 7: 847-854.
128. Widdowson PS, Ordway GA, Halaris AE (1992). Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 59: 73-80.
129. Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, Kennedy P et al (2011). A novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 31: 9084-9092.
130. Wilkinson MB, Xiao G, Kumar A, LaPlant Q, Renthal W, Sikder D et al (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 29: 7820-7832.
131. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90-110.
132. Wolffe AP, Hayes JJ (1999). Chromatin disruption and modification. Nucleic Acids Res 27: 711-720.
133. Wu C, Morris JR (2001). Genes, genetics, and epigenetics: a correspondence. Science 293: 1103-1105.
134. Xu H, Steven Richardson J, Li XM (2003). Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28: 53-62.
135. Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S (2011). Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry (e-pup ahead of print 3 August 2012).
136. Zhang DE, Nelson DA (1988). Histone acetylation in chicken erythrocytes. Rates of deacetylation in immature and mature red blood cells. Biochem J 250: 241-245.
137. Zhang TY, Hellstrom IC, Bagot RC, Wen X, Diorio J, Meaney MJ (2010). Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. J Neurosci 30: 13130-13137.
138. Zhang W, Bone JR, Edmondson DG, Turner BM, Roth SY (1998). Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J 17: 3155-3167.
139. Zhu H, Huang Q, Xu H, Niu L, Zhou JN (2009). Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors. Behav Brain Res 196: 200-206.